The original success of Sildenafil undeniably revolutionized the pharmaceutical landscape, but placing funds in companies strongly reliant on off-patent versions presents a complex picture. Although early returns were impressive, the end of patents and the appearance of discounted alternatives have eroded the customer base. Therefore, a thorough… Read More